Biotech Clinches Latest Funding Round With $55M In Tow

By Jade Martinez-Pogue · June 14, 2024, 3:00 PM EDT

Biotechnology company Enveda Biosciences on Friday announced that it has closed its most-recent financing round after raising $55 million from investors, bringing the Boulder, Colorado-based company's total capital fundraising to $230...

To view the full article, register now.